Logo image of SLAB

SILICON LABORATORIES INC (SLAB) Stock Fundamental Analysis

USA - NASDAQ:SLAB - US8269191024 - Common Stock

131.74 USD
-0.59 (-0.45%)
Last: 10/30/2025, 4:20:00 PM
131.74 USD
0 (0%)
After Hours: 10/30/2025, 4:20:00 PM
Fundamental Rating

4

SLAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While SLAB has a great health rating, there are worries on its profitability. SLAB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SLAB has reported negative net income.
SLAB had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SLAB reported negative net income in multiple years.
In multiple years SLAB reported negative operating cash flow during the last 5 years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of SLAB (-8.57%) is worse than 72.32% of its industry peers.
SLAB's Return On Equity of -9.86% is on the low side compared to the rest of the industry. SLAB is outperformed by 66.96% of its industry peers.
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

SLAB has a Gross Margin of 54.95%. This is in the better half of the industry: SLAB outperforms 75.89% of its industry peers.
SLAB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

8

2. Health

2.1 Basic Checks

SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SLAB has more shares outstanding
The number of shares outstanding for SLAB has been reduced compared to 5 years ago.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 18.13 indicates that SLAB is not in any danger for bankruptcy at the moment.
SLAB's Altman-Z score of 18.13 is amongst the best of the industry. SLAB outperforms 84.82% of its industry peers.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.13
ROIC/WACCN/A
WACC11.63%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 5.12 indicates that SLAB has no problem at all paying its short term obligations.
SLAB has a better Current ratio (5.12) than 75.89% of its industry peers.
A Quick Ratio of 4.45 indicates that SLAB has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.45, SLAB is doing good in the industry, outperforming 76.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 4.45
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

SLAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.76%, which is quite impressive.
SLAB shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.65%.
Measured over the past years, SLAB shows a small growth in Revenue. The Revenue has been growing by 4.28% on average per year.
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%

3.2 Future

SLAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.51% yearly.
SLAB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.71% yearly.
EPS Next Y143.45%
EPS Next 2Y86.42%
EPS Next 3Y64.51%
EPS Next 5YN/A
Revenue Next Year34.95%
Revenue Next 2Y26.81%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

SLAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 51.92 indicates a quite expensive valuation of SLAB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SLAB is on the same level as its industry peers.
SLAB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.63.
Industry RankSector Rank
PE N/A
Fwd PE 51.92
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

SLAB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SLAB is cheaper than 63.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 57.59
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

SLAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SLAB's earnings are expected to grow with 64.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.42%
EPS Next 3Y64.51%

0

5. Dividend

5.1 Amount

No dividends for SLAB!.
Industry RankSector Rank
Dividend Yield N/A

SILICON LABORATORIES INC

NASDAQ:SLAB (10/30/2025, 4:20:00 PM)

After market: 131.74 0 (0%)

131.74

-0.59 (-0.45%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners101.89%
Inst Owner Change0.24%
Ins Owners1.87%
Ins Owner Change2.15%
Market Cap4.32B
Revenue(TTM)703.20M
Net Income(TTM)-104614000
Analysts74.12
Price Target152.24 (15.56%)
Short Float %4.71%
Short Ratio6.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.72%
Min EPS beat(2)12.85%
Max EPS beat(2)16.59%
EPS beat(4)3
Avg EPS beat(4)16.76%
Min EPS beat(4)-0.51%
Max EPS beat(4)38.1%
EPS beat(8)6
Avg EPS beat(8)13.41%
EPS beat(12)8
Avg EPS beat(12)11.9%
EPS beat(16)12
Avg EPS beat(16)23.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-1.82%
Revenue beat(4)0
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)-1.26%
Revenue beat(8)1
Avg Revenue beat(8)-0.77%
Revenue beat(12)2
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)0%
PT rev (3m)6.13%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)25.1%
EPS NY rev (1m)1.38%
EPS NY rev (3m)15.13%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.92
P/S 6.15
P/FCF 57.59
P/OCF 45.61
P/B 4.07
P/tB 6.58
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)2.54
Fwd EY1.93%
FCF(TTM)2.29
FCFY1.74%
OCF(TTM)2.89
OCFY2.19%
SpS21.43
BVpS32.33
TBVpS20.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM 10.68%
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 44.06%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.12
Quick Ratio 4.45
Altman-Z 18.13
F-Score6
WACC11.63%
ROIC/WACCN/A
Cap/Depr(3y)38.21%
Cap/Depr(5y)38.21%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
EPS Next Y143.45%
EPS Next 2Y86.42%
EPS Next 3Y64.51%
EPS Next 5YN/A
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%
Revenue Next Year34.95%
Revenue Next 2Y26.81%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y32.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.24%
EBIT Next 3Y63.12%
EBIT Next 5YN/A
FCF growth 1Y563.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y724.28%
OCF growth 3YN/A
OCF growth 5YN/A

SILICON LABORATORIES INC / SLAB FAQ

What is the ChartMill fundamental rating of SILICON LABORATORIES INC (SLAB) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SLAB.


Can you provide the valuation status for SILICON LABORATORIES INC?

ChartMill assigns a valuation rating of 3 / 10 to SILICON LABORATORIES INC (SLAB). This can be considered as Overvalued.


How profitable is SILICON LABORATORIES INC (SLAB) stock?

SILICON LABORATORIES INC (SLAB) has a profitability rating of 1 / 10.